Mintr Compass
$91.14
EW · Edwards Lifesciences
71 Strengthening · Mid Horizon
71Strengthening
Price Action60
Business Quality48
Market Confidence86
AI READ as of 2026-08-20
Trading Strong
  • Recent news coverage remains mostly positive
  • Technical indicators are showing signs of improvement
Investing Weak
  • The current price is expensive relative to the company value
  • Fundamental business growth and quality metrics appear average
  • The broader healthcare industry faces significant competitive pressures
Price & Momentum · Trading
Technical
68
Rel. Strength
54
Momentum
60
Proximity
58
Sentiment
91
Business & Value · Investing
Quality
51
Balance Sheet
62
Growth
55
Valuation
25
Analyst
80
Open EW in Compass →
Ratings current as of 2026-08-19. Price live as of 2026-08-20 14:30 UTC. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy